SEC Form 4 · accession 0001179110-18-008176
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dean L Schorno
Officer — EVP &Chief Financial Officer
Period of report
Jun 4, 2018
Accepted (ET)
Jun 6, 2018 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.44 | Jun 4, 2018 | A | 167,500 | A | — | Jun 4, 2028 | Common Stock | 167,500 | 167,500 | D |
Explanation of responses
- F1One fourth (1/4th) of the option vests one year from June 4, 2018 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.